CYCC icon

Cyclacel Pharmaceuticals
CYCC

Overview Fund Activity

26 hedge funds and large institutions have $1.23M invested in Cyclacel Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 0 closing their positions.

Holders
26
Holders Change
+5
Holders Change %
+23.81%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
–
Calls
–
Puts
$9K
Net Calls
-$9K
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$107K
2
SM
2
Sabby Management
Florida
$628K
3
Goldman Sachs
3
Goldman Sachs
New York
$41K
4
VKH
4
Virtu KCG Holdings
New York
$4K
5
LTFS
5
Ladenburg Thalmann Financial Services
Florida
$1K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$351K
2
Citadel Advisors
2
Citadel Advisors
Florida
$15K
3
UBS Group
3
UBS Group
Switzerland
$1K
Name Market Value Shares Shares
Change 		Shares
Change %
CI
26
Cowen Inc
New York
$0 52,521 +52,521 New
1
2